SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event report): March 15, 2005 AMS HEALTH SCIENCES, INC. (Exact Name of Registrant as Specified in its Charter) OKLAHOMA 001-13343 73-1323256 (State or Other (Commission File (IRS Employer Jurisdiction of Number) Identification Incorporation or Number) Organization) 711 NE 39th Street, Oklahoma City, OK 73105 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (405) 842-0131 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Information To Be Included in the Report Item 2.02. Results of Operations and Financial Condition. On March 15, 2005, AMS Health Sciences, Inc. (the "Company") announced financial results for the year ended December 31, 2004. The press release is attached hereto as Exhibit 99.1. Item 8.01. Other Events. Also announced by press release on March 15, 2005, the Company signed an investment banking agreement with The Seidler Companies Incorporated through which Seidler will actively seek new product acquisition, licensing opportunities and strategic investors, and will evaluate industry opportunities to enhance shareholder value. The press release is attached hereto as Exhibit 99.2 Item 9.01. Financial Statements and Exhibits. Exhibit No. Description ----------- ----------- 99.1 Press release dated March 15, 2005. 99.2 Second press release dated March 15, 2005. SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereto duly authorized. AMS HEALTH SCIENCES, INC. REGGIE COOK By: Reggie Cook Chief Financial Officer Date: March 17, 2005 EXHIBIT INDEX Exhibit No. Description Method of Filing ----------- ----------- ---------------- 99.1 Press release dated March 15, 2005, Filed herewith electronically announcing financial results for the year ended December 31, 2004 99.2 Press release dated March 15, 2005, Filed herewith electronically announcing execution of an investment banking agreement with The Seidler Companies, Incorporated